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Summary: We report a method for the determination of ISß-glycyrrhetinic acid (glycyrrhetinic acid) in human
serum using the ALCA-system. The technology of the ALCA-system is based on the principles of adsorptive and
desorptive processes between liquid and solid phases. The assay is run fully automated and selective. Procedural
losses throughout the analysis are negligible, thereby allowing for external calibration. The calibration curve is
linear up to 10 mg/1 and concentrations as low as 10 ^ are detectable. CV is 2.5% for within- and 7.5% for
between-assay precision at a level of 50 g/l and 1.2% for within- and 8.5% for between-assay precision at a level
of 500 g/l. Specific and expensive reagents are not necessary and time-consuming manual operations are not
involved. This assay can be selected from a wide spectrum of methods at any time. Thus, the present method is
well-suited for drug monitoring purposes in the routine laboratory. In a pharmacokinetic study we measured serum
levels of glycyrrhetinic acid in ten healthy young volunteers after ingestion of 500 mg glycyrrhetinic acid. Maximum
levels of glycyrrhetinic acid were 6.3 mg/1 2 to 4 hours after ingestion. Twenty-four (24) hours after ingestion seven
probands still had glycyrrhetinic acid levels above the detection limit with a mean level of 0.33 mg/1.
Introduction
Glycyrrhetinic acid (fig. 1), the aglycon of glycyrrhizin,
is a natural compound of the roots of Glycyrrhiza glabra
L. For thousands of years it has been used as a sweeten-
ing agent as well as for therapeutic purposes (1). In 1946
Revers et al. (2) reported on the treatment of peptic ul-
cers with succus liquiritiae. Later he observed that about
20% of the patients treated with this medication devel-
oped edema and hypertension (3). Subsequently, this lic-
orice-induced form of hypertension mediated by glycyr-













Fig. 1 Structure of glycyrrhizin and its aglycon glycyrrhetinic
acid.
Methods for quantitative determination of glycyrrhetinic
acid in human serum include thin layer chromatography
(8), immunoassay techniques (9, 10), gas chromatogra-
phy with mass spectrometry (11) and liquid chromato-
graphy (12—23). Most Chromatographie procedures re-
quire time-consuming and tedious extraction steps for
example enrichment, preconcentration and prepurifica-
tion. Therefore liquid extraction or solid-phase extrac-
tion steps, sometimes combined with ion-pairing (12,
16, 17, 21), are used. An internal calibration is almost
always necessary. Even the immunoassay procedures re-
quire prepurification steps when specific and sensitive
results are intended.
We wanted to develop a non-immunological method for
the determination of glycyrrhetinic acid that is imple-
mented in a fully automated analytical system (auto-
matic liquid Chromatographie analyzer; ALCA) that al-
lows for analyses to be run fully automated, selectively
and within 17 minutes.
Materials and Methods
Materials
Glycyrrhetinic acid was obtained from Aldrich Chemie (Steinheim,
Germany). All aqueous buffers were ready-to-use formulations
(Chromsystems, München, Germany). The different pH buffers are
mixed "on-line" by the pumps of the ALCA-system.
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Apparatus
The ALCA-system (Ancos) has been described in detail elsewhere
(24—26) and is being used for the determination of other analytes.
For the present method it has been slightly modified. The system
consists of the sample clean-up unit, the chemical modulator unit
and the analytical unit. The clean-up unit consists of pump 1 with
a quarternary mixing device, an autosampler and precolumn 1
packed with reversed-phase material (PRP-I, 15 μηι; Hamilton,
Reno, NV, USA). The chemical modulator unit consists of the mix-
ing chamber, precolumn 2 (packed with octadecyl-silica, 5 μηι;
Shandon Southern Products, Cheshire, UK) and pump 3. The ana-
lytical unit consists of pump 2, the analytical column (packed with
octadecyl-silica, 5 μηι; Shandon) and the UV-detector.
Sample preparation
Five hundred (500) microlitres of serum are mixed with 1 ml of
citric acid (1 mol/1). No other sample preparation steps are necess-
ary.
On-line procedure
The following analytical steps are time-controlled by the ALCA-
system in such a manner that steps 1—3, as well as 7 and 8, are
run concomitantly with the Chromatographie step 6 (for more de-
tails refer to 1. c. (24-26)).
Step 1
The sample is transferred into the sampling loop of the autosam-
pler. Concomitantly, precolumn 1 is equilibrated with a pH 8
buffer.
Step 2
The sampling loop is switched into the analytical line and the sam-
ple is transferred onto precolumn 1. All lipophilic compounds are
adsorbed, polar compounds are eluted.
Step 3
A mixture of pH 8 buffer and methanol (28 + 52, by vol.) is deliv-
ered by pump 1 at a flow-rate of 2.5 ml/min. Substances more
polar than glycyrrhetinic acid are eluted from precolumn 1 into
the waste.
Step 4
A mixture of pH 8 buffer and methanol (18 + 82, by vol.) is deliv-
ered at a flow-rate of 1.3 ml/min; the glycyrrhetinic acid-containing
fraction is eluted into the mixing chamber.
Step 5
Trifluoroacetic acid (1 mol/1) is delivered by pump 3 into the mix-
ing chamber at a flow-rate of 1.5 ml/min. The glycyrrhetinic acid
containing fraction is transferred to and focused onto the top of
precolumn 2.
ual molecules more lipophilic than glycyrrhetinic acid are eluted
into the waste.
StepS
pH 8 buffer is delivered through precolumn 1; the matrix of precol-
umn 1 is equilibrated and prepared for adsorption of the next sam-
ple.
Ingestion of glycyrrhetinic acid
Ten healthy male students (aged 24 to 38 years) volunteered for
the study. The course and the protocols of the study were explained
to them carefully before they consented to participate. None of
them had obvious evidence of metabolic, endocrine, renal, or he-
patic disease. All denied taking any drugs or any preparation con-
taining glycyrrhizin or glycyrrhetinic acid.
On the first day of the study 500 mg glycyrrhetinic acid were given
orally at 8.°° a.m. Blood samples were taken 0, 2, 4, 7 and 10
hours after ingestion. Another blood sample was taken at 8.°° a. m.
on the second day. Blood specimens were centrifuged immediately
(1750g) and serum was stored frozen until analysis.
Results and Discussion
Procedural variables
Clean-up and chromatographical conditions
Glycyrrhetinic acid is an acidic drug. Control of the
eluent pH, therefore, can convert this molecule from a
neutral into an anionic species, and vice versa. Corre-
spondingly, the plot of the retention time versus the pH
shows an inflection point at about pH 7 (fig. 2). For the
preconcentration and cleaning-up of glycyrrhetinic acid,
we used a pH 8 eluent. Then, glycyrrhetinic acid is
eluted into the mixing chamber by increasing the metha-
nol fraction. Admixing of trifluoroacetic acid into the
mixing chamber at a flow-rate of 1.5 ml/min by pump
3 decreases the pH of the eluent as well as the concen-
tration of methanol, so that the neutral form of glycyr-
rhetinic acid is focused onto the top of precolumn 2. By
switching this column in line with the analytical column,
glycyrrhetinic acid is transferred to the analytical col-
umn and efficiently separated from substances that have
a physicochemical and chromatographical behaviour
similar to glycyrrhetinic acid.
Step 6
Precolumn 2 is switched into line with the analytical column. A
gradient of acetonitrile (raising from 60 to 90% within 8 min) in
pH 3 buffer is delivered by pump 2 at a flow-rate of 1.3 ml/min; the
prepurified, focused fraction is chromatographed on the analytical
column and separated glycyrrhetinic acid is quantified at 250 nm
with the UV-detector. Then 100% acetonitrile is delivered by pump
2 for l min, followed by a mixture of acetonitrile and pH 3 buffer
(60 + 40, by vol.); the analytical column is cleaned and prepared
for the next sample.
Step 7
In back-flush mode, an acetonitrile/trifluoroacetic acid gradient is







Fig. 2 Retention time of glycyrrhetinic acid on precolumn 1 in
dependency on different pH levels of the eluent.
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Efficacy of sample clean-up
The efficacy of the sample clean-up procedure for elimi-
nation of non-specific, UV-absorbing chromogens was
studied in serum samples spiked with 2.5 mg/1 glycyr-
rhetinic acid. When the complete clean-up procedure is
used, only a few non-interfering peaks are discernible
in the final chromatogram (fig. 3 A). The corresponding
chromatogram from the same serum sample injected di-
rectly into the analytical system after manual solid-
phase extraction (fig. 3B) demonstrates the large in-
terfering matrix background.
Procedural losses
To investigate the potential loss of glycyrrhetinic acid
during the complete multistep analytical procedure, 100
mg/1 glycyrrhetinic acid dissolved in methanol and
phosphoric acid, 0.02 mol/1 (50 + 50, by vol.), was as-
sayed. The eluate, which was not transferred to the ana-
lytical column, was monitored in the detector. No UV
absorbance was detected, thus indicating that glycyrrhet-
inic acid was transferred almost quantitatively to the an-
alytical column. During routine analyses, a check for
potential analytical losses was run every tenth sample.
Stability and quality of the Chromatographie system
For 600 serum samples that had been analyzed with the
same instrument settings, the Chromatographie resolu-
tion and peak shape were of consistent quality, as was
the recovery of 2.5 mg/1 glycyrrhetinic acid in a serum
sample. There was no significant alteration of the reten-
tion time.
Memory effect
There was a memory effect of 5.65% when pure water
was analyzed immediately following a sample contain-
ing 10 mg/1 of glycyrrhetinic acid. Thus, low-level sam-
Time
Fig. 3 Chromatograms of a serum sample spiked with glycyrrhet-
inic acid (2.5 mg/1) with (A) and without (B) using the full clean-
up procedure of the ALCA system.
1 = glycyrrhetinic acid.
pies run immediately after high-level samples have to
be corrected correspondingly or have to be rerun, this
memory effect is not due to residual amounts of glycyr-
rhetinic acid within the Chromatographie system, but to
the attaching of glycyrrhetinic acid to the teflon tubings
in the sampling unit. Whereas the lipophilic glycyrrheti-
nic acid molecule is efficiently transported by organic
mobile phases throughout the Chromatographie system,
it is significantly adsorbed onto to the lipophilic teflon
surface, which is only flushed with polar solvents. Theo-
retically, this memory effect, therefore, could be elimi-
nated by running a pure methanol sample after each se-
rum sample. However, this procedure would render the
method rather uneconomical and time-consuming.
Analytical variables
Standard curve and sensitivity
A standard curve for external calibration was set up in
a serum sample, the concentrations ranging from 20 g/l
to 10 mg/1. A linear calibration curve over the whole
range was obtained when the peak area was evaluated
(y = 505.5x + 16260.2; r = 0.9998). The detection
limit (a signal threefold the height of the noise level)
was about 10 g/l. The sensitivity can be increased when
I ml serum is mixed with 0.5 ml citric acid, but this may
reduce the longevity of precolumn 1. Unknowns were
estimated by their peak area and the response factor
from the calibration curve. This response factor was re-
checked every twentieth sample by assaying a sample
spiked with 500 g/l of glycyrrhetinic acid.
Imprecision
Imprecision was assessed by replicate analyses (n = 8)
of normal serum samples spiked with 50 or 500 g/l.
Coefficients of variation were 2.5% for intra-assay
precision and 7.5% for inter-assay precision at a level
of 50 g/l and 1.2% for intra-assay precision and 8.5%
for inter-assay precision at a level of 500 g/l. The coef-
ficient of variation for the precision of the retention time
was 0.1% (intra-assay; n = 30).
Accuracy
Since accuracy control samples were not commercially
available, analytical accuracy was determined by com-
paring the appropriate peak area of aqueous and serum
samples spiked with 10 g/l to 50 mg/1 glycyrrhetinic
acid. Accuracy was 98.5 ± 1.8% (n = 12).
Selectivity
Serum samples of 10 healthy young volunteers before
and after ingestion of 500 mg of glycyrrhetinic acid
were assayed. In four of the samples before ingestion
of glycyrrhetinic acid there was no UV-absorbing peak
eluting with a retention time similar to glycyrrhetinic
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acid. The other samples showed a UV-absorbing peak
eluting with a retention time near that of glycyrrhetinic
acid. In four cases this peak would simulate a concentra-
tion of glycyrrhetinic acid between 10 and 20 μg/l. The
other two cases had a concentration of 50 μg/l. These
concentrations were about 130 times below the mean
maximum levels and about 6 times below the mean
levels 24 hours after administration of glycyrrhetinic
acid. Thirty-three (33) additional samples from in-pa-
tients were analyzed. Six (6) samples showed a UV-ab-
sorbing peak with a retention time adjacent to that of
glycyrrhetinic acid (18.2%). These peaks, if not discrim-
inated as specific peaks, would simulate a concentration
of glycyrrhetinic acid of 50 to 100 μg/l in 3 and below
50 μg/l in the remaining cases.
Pharmacokinetics of glycyrrhetinic acid
The serum levels of glycyrrhetinic acid in 10 healthy
young volunteers after ingestion of 500 mg of glycyrrhe-
tinic acid are shown in figure 4. Maximum levels were
reached after 2 (in 4 probands) or 4 hours (in 5 pro-
bands). One proband showed similar levels at both
times. The mean maximum concentration was 6.3 ±3.1
mg/1 (mean ± SD). Twenty-four (24) hours after in-
8 12 16
Time after ingestion [h]
24
Fig. 4 Mean serum levels of glycyrrhetinic acid in ten healthy
young volunteers before and 2, 4, 7, 10 and 24 hours after oral
administration of 500 mg of glycyrrhetinic acid (mean ± SD).
gestion of glycyrrhetinic acid 7 probands still had mea-
surable levels with a mean concentration of 329.9 μ§/1.
These data are similar to those described by Kr henb hl
et al. (22, 23). He administered three different doses of
glycyrrhetinic acid (500, 1000 and 1500 mg) and found
maximum serum concentrations of 4.5 ± 0.9 mg/1 at 3.1
± 0.3 hours after ingestion. For the two higher doses he
described a second elimination phase that was not seen
at a dose of 500 mg. In another study De Groot et al.
(12) administered 400 and 800 mg glycyrrhizin daily
over 4 weeks (corresponding to 229 and 458 mg of gly-
cyrrhetinic acid, respectively). In this study the levels of
glycyrrhetinic acid were much lower compared with our
data (0.5—1.7 mg/1). This may be explained with the
need of conversion of glycyrrhizin to glycyrrhetinic acid
in the intestinal tract as reported by Sakiya et al. (19).
He found plasma concentrations of about 30 mg/1 for
glycyrrhetinic acid in rats after high oral doses (500 mg/
kg glycyrrhizin), but no measurable plasma levels after
a bolus injection of glycyrrhizin into the portal vein.
Practicability
The practicability of the present automated method for
the determination of glycyrrhetinic acid provides distinct
advantages over earlier ones:
(1) the complete assay is fully automated, thus eliminat-
ing any manual extraction or evaporation steps;
(2) the analyte is kept in solution throughout the com-
plete assay, thereby avoiding potential losses or decom-
position;
(3) procedural losses of glycyrrhetinic acid throughout
the assay are negligible and because of the good
precision only a single external calibration is necessary
for evaluation of results; and
(4) the regeneration of the precolumns and the use of
inexpensive solvents render the method distinctly more
economical than immunoassay techniques.
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